2007
DOI: 10.1016/j.lfs.2006.09.041
|View full text |Cite
|
Sign up to set email alerts
|

Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
101
3
2

Year Published

2010
2010
2020
2020

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 131 publications
(114 citation statements)
references
References 45 publications
6
101
3
2
Order By: Relevance
“…The administration of a higher dose (50 mg/kg/day) for a period of 22 weeks in obese rats reduced not only blood pressure but also other symptoms of the metabolic syndrome. Fasting glucose levels also decreased, insulin sensitivity increased, HDL levels increased and plasma triglyceride and non-esterified fatty acid levels decreased 50 .…”
Section: Astaxanthin and Chronic Diseasesmentioning
confidence: 97%
“…The administration of a higher dose (50 mg/kg/day) for a period of 22 weeks in obese rats reduced not only blood pressure but also other symptoms of the metabolic syndrome. Fasting glucose levels also decreased, insulin sensitivity increased, HDL levels increased and plasma triglyceride and non-esterified fatty acid levels decreased 50 .…”
Section: Astaxanthin and Chronic Diseasesmentioning
confidence: 97%
“…One of the mechanisms may be through ameliorating impaired lipid metabolism by increasing adiponectin level and improving insulin sensitivity [58]. Recently, Bhuvaneswari et al [59] also evaluated the effects of astaxanthin in obese mice fed a high fat plus high fructose diet, and showed that astaxanthin restricted weight gain, promoted insulin sensitivity, and prevented liver injury by decreasing cytochrome P 4502E1, myeloperoxidase, and nitro-oxidative stress, and improving the antioxidant status.…”
Section: Hepatoprotective Effectmentioning
confidence: 99%
“…1) Thus, they provide a useful model of the metabolic syndrome. 2,3) Hypertensive rats that spontaneously developed as a colony from normotensive WKY, were named SHR. 4) By crossing SHR with Sprague-Dawley (SD) rats, obese spontaneously hypertensive rats, Koletsky strain, were obtained; this strain of rats is heterozygous for the cp gene.…”
mentioning
confidence: 99%